The role of salt-inducible kinases on the modulation of renal and intestinal Na


Journal

European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354

Informations de publication

Date de publication:
05 Aug 2021
Historique:
received: 06 03 2021
revised: 24 04 2021
accepted: 30 04 2021
pubmed: 15 5 2021
medline: 6 11 2021
entrez: 14 5 2021
Statut: ppublish

Résumé

Type 1 salt-inducible kinases (SIK1) has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. Type 2 SIK (SIK2) modulates various biological functions and acts as a signal transmitter in various pathways. To evaluate the role of both SIK isoforms in renal and intestinal Na

Identifiants

pubmed: 33989615
pii: S0014-2999(21)00306-X
doi: 10.1016/j.ejphar.2021.174153
pii:
doi:

Substances chimiques

Sodium Chloride, Dietary 0
salt-inducible kinase-2, mouse EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1
Sik1 protein, mouse EC 2.7.11.1
Sodium-Potassium-Exchanging ATPase EC 7.2.2.13

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

174153

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Tatiana António (T)

Unit of Pharmacology and Therapeutics, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal; MedInUp - Center for Drug Discovery and Innovative Medicines, University of Porto, 4200-319, Porto, Portugal.

Dina Cosme (D)

Unit of Pharmacology and Therapeutics, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal; MedInUp - Center for Drug Discovery and Innovative Medicines, University of Porto, 4200-319, Porto, Portugal.

Bruno Igreja (B)

Division of Research and Development, BIAL-Portela & C(a), S.A, 4745-457, Coronado, Portugal.

Sónia Fraga (S)

Unit of Pharmacology and Therapeutics, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal; MedInUp - Center for Drug Discovery and Innovative Medicines, University of Porto, 4200-319, Porto, Portugal.

Maria Paula Serrão (MP)

Unit of Pharmacology and Therapeutics, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal; MedInUp - Center for Drug Discovery and Innovative Medicines, University of Porto, 4200-319, Porto, Portugal.

Nuno M Pires (NM)

Division of Research and Development, BIAL-Portela & C(a), S.A, 4745-457, Coronado, Portugal.

Patrício Soares-da-Silva (P)

Unit of Pharmacology and Therapeutics, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal; MedInUp - Center for Drug Discovery and Innovative Medicines, University of Porto, 4200-319, Porto, Portugal; Division of Research and Development, BIAL-Portela & C(a), S.A, 4745-457, Coronado, Portugal. Electronic address: pss@med.up.pt.

Articles similaires

Humans Meals Time Factors Female Adult

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

Classifications MeSH